Modular Medical Appoints Kevin Schmid as Chief Operating Officer

Rhea-AI Summary

Modular Medical, Inc. (NASDAQ:MODD) announced the appointment of Kevin Schmid as Chief Operating Officer, bringing over 40 years of experience in medical devices and drug delivery. Previously, Schmid served at Insulet Corporation, helping develop innovative drug delivery systems like the Omnipod. His expertise in high-volume manufacturing and operational leadership is expected to aid Modular Medical's transition to commercialization of its insulin delivery technology, aimed at improving affordability and access for diabetes management.

Positive

• Kevin Schmid's extensive background in drug delivery and manufacturing can strengthen Modular Medical's operational capabilities.
• His previous successes at Insulet indicate a potential for effective product commercialization.
• Schmid's leadership may enhance strategic direction and growth in the diabetes management sector.

Negative

• None.

Schmid brings 40 years of experience in medical devices for drug delivery and diabetes management and a background in high-volume manufacturing

SAN DIEGO, CA / ACCESSWIRE / July 26, 2022 / Modular Medical, Inc. (the "Company" or "Modular Medical")(NASDAQ:MODD) today announced that it has appointed industry veteran Kevin Schmid as its Chief Operating Officer. Mr. Schmid brings extensive operations and business development leadership experience in diabetes and drug delivery. As Vice President of Operations and Business Development at Insulet Corporation, he was instrumental in the development, manufacturing, and commercialization of wearable smart drug delivery pumps such as the Omnipod Diabetes Management System, the Amgen Neulasta On Body Injector, and the Ferring Pharmaceutical LutrePulse System. His work ranged from concept and product development to scaling multi-million unit global supply chains and high volume manufacturing operations.

He was most recently the Chief Executive Officer of Common Sensing, a designer and manufacturer of disposable injector pen dose monitoring and reporting technology. Common Sensing was sold to Bigfoot Biomedical in 2021.

"Kevin's addition to the Modular Medical team adds greater industry depth and extensive manufacturing experience and relationships to enable MODD's transition to commercialization. Kevin will have a very significant role in Modular Medical's strategic direction and growth," said Paul DiPerna, Modular Medical's President and Chief Technology Officer.

"I believe Modular Medical's insulin delivery platform represents a tremendous opportunity to bring an easy-to-use, cost-effective insulin delivery system to millions of people managing diabetes every day. I am excited to join the team," said Mr. Schmid.

Mr. Schmid is a member of the board of directors of Eitan Medical, an Israel-based provider of connected infusion and wearable drug delivery solutions. He has held previous roles at the Stevanato Group and Bose Corporation.

About Modular Medical, Inc. Modular Medical, Inc. (NASDAQ:MODD) is a development-stage medical device company that intends to launch the next generation of insulin delivery technology. Using its patented technologies, the company seeks to eliminate the tradeoff between complexity and efficacy, thereby making top quality insulin delivery both affordable and simple to learn. Our mission is to improve access to the highest standard of glycemic control for people with diabetes taking it beyond "superusers" and providing "diabetes care for the rest of us."

Modular Medical was founded by Paul DiPerna, a seasoned medical device professional and microfluidics engineer. Prior to founding MODD, Mr. DiPerna was the founder (in 2005) of Tandem Diabetes and invented and designed its t:slim insulin pump.

More information is available at https://modular-medical.com.

All trademarks mentioned herein are the property of their respective owners.

CONTACT:

Jeb Besser
Chief Executive Officer
Modular Medical, Inc.
+1 (617) 399-1741
IR@modular-medical.com

SOURCE: Modular Medical, Inc.

View source version on accesswire.com:
https://www.accesswire.com/709774/Modular-Medical-Appoints-Kevin-Schmid-as-Chief-Operating-Officer

FAQ

Who is the new Chief Operating Officer of Modular Medical?

Kevin Schmid has been appointed as the Chief Operating Officer of Modular Medical.

What experience does Kevin Schmid bring to Modular Medical?

Kevin Schmid brings over 40 years of experience in medical devices, including leadership roles in diabetes management and drug delivery.

What role did Kevin Schmid have before joining Modular Medical?

He was the Chief Executive Officer of Common Sensing and previously held a significant role at Insulet Corporation.

How might Schmid's appointment impact Modular Medical?

His extensive industry experience is expected to enhance Modular Medical's transition to commercialization and strengthen its strategic direction.